{
  "title": "\ud83c\udde8\ud83c\udded Swiss Startup Scene May 2026 \u2014 Lilly's $780M LimmaTech Buy and the Basel Biotech Boom",
  "description": "May 2026 was a tale of two Switzerlands: a record CHF 612M exit as Eli Lilly agrees to acquire Schlieren-based vaccine developer LimmaTech Biologics for up to $780M, plus monster biotech raises from Windward Bio ($165M for next-gen asthma antibodies) and Nuclidium (CHF 26M extension for radiotheranostics). Meanwhile ICT saw 10 small seed rounds worth just CHF 11M total. Emma and Ryan break down the CHF 202M month \u2014 down 37% YoY but up 45% on April \u2014 unpack what Zurich's Avian (AI fire-prevention) and Stellar Alpina (detonation propulsion) tell us about deep tech momentum, and connect it to the DACH-wide capital rotation toward defense, space and frontier AI led by Helsing's $18B round and SAP's billion-euro Prior Labs acquisition. Plus: concrete advice for software engineers in Zurich on where to point a new startup right now.",
  "topic": "switzerland startup news may 2026",
  "date": "2026-06-01",
  "duration": "00:10:27",
  "size_bytes": 5685015
}